Egetis Therapeutics AB (publ)
556706-6724ActiveInnovative pharmaceutical company developing late-stage orphan drug treatments.
Overview
- 20–49
- Employees
- 100–500M SEK
- Revenue
- 2006
- Founded
Key Decision Makers
Yilmaz Mahshid
Chief Financial Officer
Karl Hård
Vice President, Head of Investor Relations and Business Development
Nicklas Westerholm
Chief Executive Officer
Anny Bedard
President Egetis North America
+16 more contacts in Funnelfeedr
Description
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on bringing novel treatments to market. The organization concentrates its efforts on projects in late-stage development, aiming for commercialization of specialized therapies. Their primary focus lies within the orpha...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556706672401
Decision Makers
20 contacts in FunnelfeedrYilmaz Mahshid
Chief Financial Officer
Karl Hård
Vice President, Head of Investor Relations and Business Development
Nicklas Westerholm
Chief Executive Officer
Anny Bedard
President Egetis North America
Christian Sonesson
Vice President Product Strategy & Development
Gunilla Osswald
Board Member
Tiago Nunes
Chief Medical Officer
Laetitia Szaller
General Counsel & Head of Compliance
Nils Hallén
Global Head of HR
Elisabeth Svanberg
Board Member
Margarida Duarte
Board Member
Sofie Broberg
Vice President Regulatory Affairs
Katayoun Welin-Berger
Vice President Technical Operations
Birgitte Volck
Board Member
Henrik Krook
Vice President Commercial Operations
Mats Blom
Chairman of the Board
Behshad Sheldon
Board Member
Katayoun (Katy) Welin-Berger
Vice President Operations
Jay Donovan Wu
Board Member
Kristina Sjöblom Nygren
Chief Medical Officer
Similar Companies
20 similar companies in FunnelfeedrPTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
AMICUS THERAPEUTICS LTD
1–4 employeesGlobal biotechnology company developing transformative medicines for rare diseases.
Swedish Orphan Biovitrum AB (publ)
200–499 employeesGlobal biopharma unlocking breakthrough therapies for rare diseases.
Alnylam Sweden AB
5–9 employeesLeading RNAi therapeutics company developing gene-silencing medicines.
NORGINE HEALTHCARE B.V.
0 employeesLeading European specialist pharmaceutical company acquiring and commercializing medicines.
Browse More
Egetis Therapeutics AB (publ) Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo